We identified the downregulation of P2X7, CD11b, and CD11c on peripheral leukocyte surface at the pre-clinical stage of AD and they were further associated with brain atrophy, cognition decline, and CSF biomarkers of AD. Here, ITGAX is linked to Alzheimer disease.